|4Feb 19, 6:00 PM ET

Apeiron Investment Group Ltd. 4

4 · ATAI Life Sciences N.V. · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2025-02-14
Transactions
  • Purchase

    Common Shares

    2025-02-14$2.10/sh+10,835,718$22,755,00840,555,215 total(indirect: By Apeiron Investment Group Ltd.)
Holdings
  • Common Shares

    (indirect: By Apeiron Presight Capital Fund II, L.P.)
    1,799,302

Documents

1 file
  • 4
    ownership.xmlPrimary

    4